Erratum to: The Women’s wellness after cancer program: a multisite, single-blinded, randomised controlled trial protocol
- Debra Anderson1Email author,
- Charrlotte Seib1, 2,
- Dian Tjondronegoro2,
- Jane Turner3, 4,
- Leanne Monterosso5, 6,
- Amanda McGuire2,
- Janine Porter-Steele1, 2, 7,
- Wei Song8,
- Patsy Yates2,
- Neil King2,
- Leonie Young7,
- Kate White9, 10,
- Kathryn Lee11,
- Sonj Hall12,
- Mei Krishnasamy13,
- Kathy Wells14,
- Sarah Balaam2 and
- Alexandra L. McCarthy15, 2
Received: 10 March 2017
Accepted: 10 March 2017
Published: 16 March 2017
The original article was published in BMC Cancer 2017 17:98
Erratum
After the publication of this work [1] errors were noticed in the Methods section of the Abstract. In the line “A single-blinded, multi-centre randomized controlled trial recruited a total of 330 women within 24 months of completion of chemotherapy (primary or adjuvant) and/or radiotherapy”, the number 330 should be corrected to 351.
In the line “All participants were assessed with these measures at baseline (at the start of the intervention), 12 weeks (at completion of the intervention), and 24 months (to determine the level of sustained behaviour change)”, 24 months should be corrected to 24 weeks.
Notes
Declarations
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Authors’ Affiliations
Reference
- Anderson D, Seib C, Tjondronegoro D, Turner J, Monterosso L, McGuire A, et al. The Women’s wellness after cancer program: a multisite, single-blinded, randomised controlled trial protocol. BMC Cancer. 2017;17:98.View ArticlePubMedPubMed CentralGoogle Scholar
